Qilian International Holding Group Ltd
NASDAQ:QLI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Qilian International Holding Group Ltd
Cash from Financing Activities
Qilian International Holding Group Ltd
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Qilian International Holding Group Ltd
NASDAQ:QLI
|
Cash from Financing Activities
-$2.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Financing Activities
-¥1.8B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Financing Activities
¥8.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Financing Activities
-¥4.3B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-22%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Cash from Financing Activities
-¥4.5B
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Cash from Financing Activities
¥1.3B
|
CAGR 3-Years
143%
|
CAGR 5-Years
144%
|
CAGR 10-Years
N/A
|
|
Qilian International Holding Group Ltd
Glance View
Qilian International Holding Group Ltd. is a pharmaceutical and chemical company. The company is headquartered in Jiuquan, Gansu and currently employs 283 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.
See Also
What is Qilian International Holding Group Ltd's Cash from Financing Activities?
Cash from Financing Activities
-2.9m
USD
Based on the financial report for Sep 30, 2023, Qilian International Holding Group Ltd's Cash from Financing Activities amounts to -2.9m USD.
What is Qilian International Holding Group Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
1%
Over the last year, the Cash from Financing Activities growth was 51%.
